<code id='B750CEFFF7'></code><style id='B750CEFFF7'></style>
    • <acronym id='B750CEFFF7'></acronym>
      <center id='B750CEFFF7'><center id='B750CEFFF7'><tfoot id='B750CEFFF7'></tfoot></center><abbr id='B750CEFFF7'><dir id='B750CEFFF7'><tfoot id='B750CEFFF7'></tfoot><noframes id='B750CEFFF7'>

    • <optgroup id='B750CEFFF7'><strike id='B750CEFFF7'><sup id='B750CEFFF7'></sup></strike><code id='B750CEFFF7'></code></optgroup>
        1. <b id='B750CEFFF7'><label id='B750CEFFF7'><select id='B750CEFFF7'><dt id='B750CEFFF7'><span id='B750CEFFF7'></span></dt></select></label></b><u id='B750CEFFF7'></u>
          <i id='B750CEFFF7'><strike id='B750CEFFF7'><tt id='B750CEFFF7'><pre id='B750CEFFF7'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:77
          RFK Jr. for first opinion
          STAT, AP

          Robert F. Kennedy Jr. said Tuesday that he will head up a panel on vaccine safety for Donald Trump.

          The president-elect’s transition team spokeswoman later walked that back, saying that he is “exploring the possibility” of forming a panel on autism, but “no decisions have been made.”

          advertisement

          Let’s hope Trump drops any idea of a vaccine panel headed by Kennedy. For more than a decade, Kennedy has promoted anti-vaccine propaganda completely unconnected to reality. If Kennedy’s panel leads to even a small decline in vaccine rates across the country, it will result in the waste of untold amounts of money and, in all likelihood, the preventable deaths of infants too young to be vaccinated.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Device maker Teleflex to acquire urology company for $600M
          Device maker Teleflex to acquire urology company for $600M

          AdobeTeleflexannouncedplansonWednesdaytoacquirePaletteLifeSciences,themakerofaslateofgel-basedproduc

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Democrats decry new health bill for going easy on private equity

          Rep.RichardNeal(D-Mass.)DrewAngerer/GettyImagesWASHINGTON— AriftbetweenDemocratsandRepublicansoverhe